Usage of 0.4% sodium hyaluronate in complex treatment of pediatric patients with dry eye syndrome against the background of allergic diseases of the organ of vision

Authors

  • L.S. Vasilyeva Commercial Non-for-profit Enterprise “Regional Eye Clinic” of Mykolaiv Regional Council, Mykolaiv, Ukraine
  • O.V. Nesterenko Commercial Non-for-profit Enterprise “Regional Eye Clinic” of Mykolaiv Regional Council, Mykolaiv, Ukraine
  • K.A. Rylkova Commercial Non-for-profit Enterprise “Regional Eye Clinic” of Mykolaiv Regional Council, Mykolaiv, Ukraine

DOI:

https://doi.org/10.22141/2309-8147.9.2.2021.241505

Keywords:

0.4% sodium hyaluronate, dry eye syndrome, allergic conjunctivitis

Abstract

Background. In recent years, the prevalence of allergic diseases of the anterior chamber of the eye has increased. They are often accompanied by the development of dry eye syndrome, which can complicate their course. Therefore, it is important to take a comprehensive approach to their diagnosis and treatment. The purpose was to study the effectiveness of 0.4% sodium hyaluronate (Gilays) in children with dry eye syndrome on the background of allergic diseases of the conjunctiva. Materials and methods. The study involved 42 patients (84 eyes) aged 3 to 18 years, who were examined and treated on the basis of Regional Eye Clinic. Patients were treated with local H-1 histamine blockers twice a day for 14 days, f necessary — with topical glucocorticoids by the scheme for 12 days. In the first group (21 patients, 42 eyes), the main treatment was added with the drugs containing 0.2% sodium hyaluronate, used topically 4 times a day for 14 days. In the second group (21 patients/42 eyes), 0.4% sodium hyaluronate (Gilays) was added to the treatment regimen. H-1 histamine blockers were not used systemically. Before starting therapy and 2 weeks later, the following values were evaluated: the changes in the anterior chamber of the eye using biomicroscopy, determination of lacrimal film rupture time, Schirmer 1 test, questionnaire. Conclusions. The use of sodium hyaluronate in the complex therapy of dry eye syndrome in allergic eye diseases is quite effective. The use of 0.4% sodium hyaluronate was more effective compared to the control group. It is advisable to use a questionnaire to communicate with the child, but it is necessary to refine the form of questions to eliminate as much as possible the subjectivity of the data.

Downloads

Download data is not yet available.

References

Бахритдинова Ф.А., Миррахимова С.Ш., Нарзикулова К.И. и др. Оптимизация лечения синдрома сухого глаза при аллергических конъюнктивитах. Офтальмол. журн. 2020. № 2. С. 30-35.

Веселовська Н.М., Шаргородська І.В. Комплексний та мультидисциплінарний підхід у диференційній діагностиці та лікуванні кон’юнктивіту у дітей. Педіатрія. 2020. № 4 (55).

Дрожжина Г.І., Гайдамака Т.Б., Тройченко Л.Ф. Вплив препаратів, які заміщують сльозу, з різним вмістом натрію гіалуронату на стан переднього відділу ока у хворих з синдромом сухого ока. Офтальмологічний журнал. 2016. № 6. С. 6-11.

Зайков С.В., Гришило П.В., Гришило А.П. Сучасні підходи до діагностики та лікування алергічного кон’юнктивіту. Здоров’я України. 2015, серпень. № 15–16 (364–365).

Майчук Д.Ю., Лошкарева А.О. Особенности терапии пациентов с синдромом сухого глаза, в том числе с нарушением эпителизации роговицы. Офтальмология. 2019. № 16(4). С. 529-536.

Kubicka-Trzaska A., Romanowska-Dixon В. Dry eye syndrome and allergic conjunctivitis — epidemics of XXI century — diagnostic problems and management. Przegl. Lek. 2009. Vol. 66(11). Р. 967-71.

Handan Akil, Fatih Celik, Fatih Ulas, Ilknur Surucu Kara. Dry Eye Syndrome and Allergic Conjunctivitis in the Pediatric Population. Middle East Afr. J. Ophthalmol. 2015 Oct-Dec. Vol. 22(4). Р. 467-471.

Kent С. Is It Dry Eye, Allergy Or Infection? Review of Ophthalmology. 2014.

Milton M. Hom, Andrew L. Nguyen, Leonard Bielory. Allergic conjunctivitis and dry eye syndrome. Ann. Allergy Asthma Immunol. 2012 Mar. Vol. 108(3). Р. 163-6.

Villani E., Rabbiolo G., Nucci P. Очні форми алергії як фактор ризику розвитку синдрому сухого ока. Медичне здоров’я України XXI століття. 2018 рік, грудень.

Stapleton F., Alves M., Bunya V.Y. et al. TFOS DEWS II epidemiology report. Ocul. Surf. 2017. Vol. 15. Р. 334-365. DOI: 10.1016/j.jtos.2017.05.003.

Published

2022-01-11

Issue

Section

Exchange of Experience